The tweet was deleted by the author.
But we saved everything 🙂.
Arvinas has announced its participation in the Michael J Fox Foundation’s LITE and PPMI programs to support Parkinson disease research.
The company stated that these collaborations are aimed at deepening the understanding of LRRK2 biology, a key area of scientific investigation in Parkinson disease. By joining these initiatives, Arvinas seeks to contribute to the development of innovative new approaches for Parkinson disease and related conditions. Details on specific research milestones or timelines were not disclosed.
View post on X Loading...
Arvinas recently delivered its first quarter 2026 financial results, reporting stable earnings. The company also provided a corporate update on its ongoing initiatives during the same announcement. These activities come as Arvinas expands its collaborations in Parkinson disease research.